The Hydropothecary Corporation

HEXO stock has returned 88 percent YTD. Recently, the stock has lost some of its value. Will HEXO stock fall more or go up?

In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter.

Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1.

Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.

CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.

On December 16, Canopy Growth was trading at 26.79 Canadian dollars, implying a rise of 9.6% since its fiscal 2020 second-quarter earnings release.

In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x.

Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.

Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why.

Marijuana is illegal in South Dakota. However, the state decided to make both recreational and medical marijuana legal this year.

Legal cannabis for medical purposes has been available for several years, yet you’ll often hear people say that cannabis lacks science.

According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil.

With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.

On October 17, Cannabis 2.0 legalized edibles, beverages, and concentrates in Canada. As the country waits for the benefits, is Cannabis 3.0 next?

In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws.

Marijuana laws are pretty strict in Texas, but could this change? Here are five things you need to know about the state’s relationship with marijuana.

Canopy Growth (NYSE:CGC) lost 25.4% in 2019. The company reported weak sales and higher-than-expected operating losses in the last two quarters.

Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.

The reason cannabis stocks are rising could be because October 17 is approaching.

Canopy Growth (CGC) has seen dizzying ups and gloomy downs in 2019. The stock jumped up by 79.91% from $28.92 on January 2 to $52.03 on April 29.

Aurora Cannabis (ACB) wants to grow cannabis outdoors. In July, it received Health Canada licenses for outdoor cultivation at two Canadian sites.

Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.

Canopy Growth has struggled this year. Despite all their strategies, cannabis companies have failed to hit revenue and profitability targets this year.

It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

Recreational cannabis isn’t legal in Utah. Although the state legalized medical cannabis in 2018, the medical marijuana program will go live in March 2020.

Mexico has delayed marijuana legalization. The Supreme Court’s deadline for legalization was October 23. The delay could stretch into November.

A recent Gallup poll data found that nearly 66% of Americans support making cannabis legal. However, this figure was the same as in 2018. This suggests a standstill in the rise in support of cannabis legalization. Moreover, nine states will be voting in 2020 on measures to allow cannabis for recreational or medical use. The […]

As market analysts increasingly predict an upcoming global recession, we take a look at the impact of a recession on cannabis stocks.

Deloitte says that the Canadian edibles market could reach 2.7 billion Canadian dollars per year. Cannabis 2.0 could help cannabis stocks recover.

Recreational cannabis isn’t legal in Maryland, but the state has been trying to launch edibles as part of its medical marijuana program.

In this morning’s edition of Get Real, we saw that WeWork’s layoffs are taking a toll. Meanwhile, the cannabis industry could be bouncing back.

The spotlight is on marijuana legalization as the demand keeps surging. More states have stepped up to legalize either recreational or medical cannabis.

For the second quarter of fiscal 2020, analysts expect Hexo’s revenue to grow 25.5% YoY (year-over-year) to 16.8 million Canadian dollars.

Charlotte’s Web Holdings (NYSEARCA:CWEB) is one of the main players in the CBD business. The company plans to keep expanding in 2020.

Marijuana legalization hopes never really ended in Nebraska. Signature gathering paused in the state amid the pandemic and the lockdown.

Marijuana legalization in Idaho had to bear the brunt of the coronavirus pandemic. The lockdown forced the state to suspend its medical marijuana campaign.

Canopy Growth laid off an unspecified number of employees on Thursday. So far, the company has laid off 800 employees this year.

Hexo (TSE:HEXO) stock has been rising high before its third-quarter earnings results. The company will likely report its results before the market bell on Thursday.

Bermuda wants to expand its legal cannabis market. The government wants public feedback before the upcoming Bermuda Parliament sessions.

On Monday, HEXO announced that it received a license amendment from Health Canada for its manufacturing and processing facility in Belleville, Ontario.

Constellation Brands (NYSE:STZ) expressed its confidence in Canopy Growth (NYSE:CGC)(TSE:WEED) by increasing its stake in the company.

Cannabis stocks have underperformed the broader markets. Despite the underperformance, Aphria’s recent financial performance was impressive.

Hexo (TSE:HEXO) has been struggling for a while now and things aren’t looking good. The stock has lost close to 70.2% year-to-date.

Canopy Growth (NYSE:CGC)(TSE:WEED) stock rose to a high of 22.66 Canadian dollars before closing at 21.46 Canadian dollars on Monday.

Aurora Cannabis announced its plan to raise capital and strengthen its liquidity position through a reverse stock split amid the financial crisis.

Medical marijuana legalization won’t happen in Idaho in 2020 due to the coronavirus pandemic. The ICC couldn’t gather the required signatures.

New York lawmakers decided to delay marijuana legalization due to the COVID-19 pandemic. As a result, New York won’t see marijuana legalization in 2020.

Hexo (TSE:HEXO) reported its second-quarter earnings on March 30. For the quarter, the company missed analysts’ revenue expectations marginally.

MedMen stock fell by 12.0% on March 30 after the company released some corporate updates. MedMen has been struggling with a cash crunch.